Quick Snapshot

LynxDx client portal showing COVID-19 PCR test results.
The client portal delivered HIPAA-compliant access to results, billing, and logistics updates for enterprise partners.

Mandate / Opportunity / Problem Scope

LynxDx pivoted from commercializing a novel prostate cancer diagnostic to scaling COVID PCR testing at the height of the pandemic. The challenge was to evolve a custom laboratory information management system (LIMS) that could orchestrate high-throughput testing, serve diverse enterprise clients, and meet strict HIPAA, CAP/CLIA, and NIST requirements.

Order management view within the LynxDx LIMS platform.
Workflow tooling streamlined high-volume orders across nursing facilities, schools, and public testing sites.
Laboratory results dashboard with filtering and export controls.
Results dashboards gave lab staff real-time visibility into queue status, QC holds, and turnaround expectations.
Mobile phone mockups of the LynxDx testing experience.
Responsive design ensured administrators and patients could check results from any device.
Infographic describing the LynxDx COVID-19 testing process.
Communications assets aligned operations, marketing, and public health messaging around the statewide testing program.

What I Led / Delivered / Highlights

Impact / Lasting Value / Takeaway

The platform underpinned LynxDx’s rise to Michigan’s leading COVID testing lab, enabling $100M in revenue while keeping patients, administrators, and clinicians aligned on timely results. Establishing a resilient, compliant, and insight-rich LIMS created a foundation the company could extend back to its core precision diagnostics mission.